ITF Enhancing Human Security

Ivanhoe Mines and Gécamines Agree on Off-Take and Financing Terms to Return the Ultra-High-Grade Kipushi Mine in the DRC to Production

Retrieved on: 
Thursday, April 27, 2023

"The off-take and financing milestones are critical deliverables that allow us to return Kipushi to production by the third quarter of next year.

Key Points: 
  • "The off-take and financing milestones are critical deliverables that allow us to return Kipushi to production by the third quarter of next year.
  • "In partnership with Gécamines, we are closing in on a monumental achievement to return the great Kipushi Mine to production.
  • KICO is 68% owned by Kipushi Holding, a wholly owned subsidiary of Ivanhoe Mines, and the remaining 32% of KICO is owned by Gécamines.
  • Back (L-R): Ludovic Monga Banza Kabongo, Deputy GM, Gécamines; Olivier Binyingo, SVP Public Affairs DRC, Ivanhoe Mines; Jack Masangu A Mwanza, Deputy GM, Gécamines; Stephane Cormier, Advisor, Gécamines.

ALT (ADVANCED LIQUID TECHNOLOGY) CANNABIS ANNOUNCES AGREEMENT WITH GROW GROUP FOR EXPANSION INTO EUROPEAN MEDICAL MARKETS

Retrieved on: 
Monday, August 16, 2021

Los Angeles, CA, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Pioneering liquid cannabis company ALT (Advanced Liquid Technology), announces it has entered into an agreement with Grow (Grow Group Plc) to market and distribute ALTs proprietary, fast-acting, liquid medical cannabis products across Europe.

Key Points: 
  • Los Angeles, CA, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Pioneering liquid cannabis company ALT (Advanced Liquid Technology), announces it has entered into an agreement with Grow (Grow Group Plc) to market and distribute ALTs proprietary, fast-acting, liquid medical cannabis products across Europe.
  • Patients will benefit from rapid on-set of effects within 5-15 minutes in addition to higher efficiency in absorption of medical cannabis.
  • ALT plans to have a range of EU GMP-certified liquid medical cannabis products available for patients in Europe by early 2022.
  • ALTs CEO, Robert Davis, commented, We are honored to partner with GROW in bringing ALTs completely differentiated brand and liquid medical cannabis technologies to the European medical markets.